James Chih-Hsin Yang

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

James Chih-Hsin Yang
Mar 25, 2025, 08:45 | Blog
Vun-Sin Lim: Reviewer workshop in Taipei with TASLC
Vun-Sin Lim, Managing Editor of the Journal of Thoracic Oncology, shared a post on LinkedIn:…
Feb 10, 2025, 09:58 | Science
Brigatinib vs alectinib in crizotinib-refractory advanced ALK+ NSCLC by James Chih-Hsin Yang et al.
In November 2022, a paper by James Chih-Hsin Yang et al. was published in Annals…
Jan 8, 2025, 12:00 | Opinion
Yakup Ergün: NSCLC Mutation Detection via Pleural Effusion cfDNA Sequencing
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: “NSCLC Mutation Detection via…
Dec 19, 2024, 11:54 | Opinion
Lung Cancer Trial Highlights from 2024 By Yakup Ergün
Yakup Ergün, Medical Oncologist at Antalya City Hospital, posted on X: “What happened in Lung…
Nov 22, 2024, 22:09 | Insight
5 papers about Lung Cancer suggested by Stephen Liu
Stephen Liu, Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers…
Nov 13, 2024, 15:39 | Blog
Yakup Ergün: An eye-opening case report for Oral propranolol for amivantamab-induced scalp ulcers
Yakup Ergün, Medical Oncologist at Bower Hospital, shared a post on X about a recent paper…
Nov 12, 2024, 19:34 | Insight
5 papers about Lung Cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Sep 10, 2024, 14:57 | Insight
Article of the day, September 10th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 1, 2024, 09:48 | Insight
Phase III Keynote-789 Trial of Platinum + Pemetrexed +/- Pembrolizumab in EGFR + NSCLC
Jarushka Naidoo shared a post on X: "Phase  III Keynote-789 Trial of Platinum + Pemetrexed +/-Pembro…
Aug 27, 2024, 21:09 | Insight
5 papers about lung cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Aug 19, 2024, 16:16 | Insight
Capmatinib and nazartinib shows promise in EGFR-mutated Lung Cancer resistant to prior treatments
EGFR Positive UK shared a post on X: "Capmatinib and nazartinib shows promise in patients with…
Jun 26, 2024, 12:05 | Insight
Piotr Wysocki: Osimertinib after radiochemotherapy improves PFS in EGFR-mutated NSCLC patients – but is it really what they need?
Piotr Wysocki recently posted on LinkedIn: "The results of the LAURA study were presented during a…
Jun 10, 2024, 00:53 | Insight
Vijith Shetty: Osimertinib Could Alter SOC for Stage III EGFR+ NSCLC
Vijith Shetty, Associate Professor and Consultant Medical Oncologist at KS Hegde Medical Academy, shared on…
Apr 26, 2024, 20:26 | Insight
New Paper Alert! Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial
Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial Authors:…
Sep 29, 2023, 18:43 | Blog
Cristian Massacesi: Just completed another inspiring trip – this time to China and Taiwan – to meet up with AstraZeneca colleagues and connect with local clinical researchers conducting trials into potential new cancer treatments.
All: 15 Posts: 1 - 100
Special Coverage